Biopharmaceutical Contract Manufacturing Market
Market Valuation: Valued at USD 28.0 billion in 2025, the global biopharmaceutical contract manufacturing market is projected to reach USD 31.0 billion in 2026, and expand to USD 63.9 billion by 2035 at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period.
Service Segments: The drug substance (API) manufacturing segment accounts for roughly 60% of overall revenue share due to lower investment costs and efficient resource utilization.
https://www.rootsanalysis.com/....reports/biopharmaceu